MSCs or MSC-conditioned medium (MSC-CM) treatment increased IL-10 and IDO levels in serum and ameliorated CCl4-induced liver fibrosis through downregulating IL-17 producing CD4+ T cells and upregulating IL-10 producing CD4+ T cells in the liver. The gene discussed is IL10; the disease is Hepatic fibrosis.